In Silico and In Vitro Evaluation of Bioactive Constituents Isolated from Ziziphus oxyphylla for the Treatment of Diabetes
Biomolecules · 09.05.2026 · 16 (5) · 700
DOI: 10.3390/biom16050700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 09.05.2026. Verfasst von Muhammad Zia-Ul-Haq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Swabi, Ambar, Swabi 94640, Khyber Pakhtunkhwa, Pakistan. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Ziziphus, Plant Extracts, Diabetes Mellitus. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qassim University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Zizyphus oxyphylla has been traditionally used in the management of metabolic disorders, and cyclopeptide alkaloids isolated from its roots have been structurally characterized, although their antidiabetic potential remains insufficiently explored. This study evaluated the antidiabetic activity of three previously isolated cyclopeptide alkaloids, Oxyphylline-D (1), Nummularine-C (2), and Nummularine-R (3), using integrated in silico molecular docking and in vitro enzyme inhibition assays. Molecular docking was performed against key diabetes-related enzymes, including α-amylase, α-glucosidase, and dipeptidyl peptidase-4, followed by validation through enzyme inhibition assays. All compounds demonstrated favorable binding affinities toward the selected targets, with compound 2 showing the most consistent performance across enzymes. In vitro results support these findings, where compound 2 exhibited inhibitory activity with IC50 values of 102.97 µg/mL (187.71 µM) against α-amylase and 28.87 µg/mL (52.62 µM) against dipeptidyl peptidase-4, comparable to standard inhibitors. Overall, the results indicate that cyclopeptide alkaloids from Z. oxyphylla possess significant multi-target antidiabetic potential, with Nummularine-C emerging as a promising candidate for further pharmacological development. These findings provide experimental support for computational predictions and reinforce the relevance of combining in silico and in vitro approaches for identifying bioactive natural products with potential therapeutic value in diabetes management, drug discovery pipelines, and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Swabi, Ambar, Swabi 94640, Khyber Pakhtunkhwa, Pakistan.
- Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
- Department of Microbiology, Kohat University of Science and Technology (KUST), Kohat 26000, Khyber Pakhtunkhwa, Pakistan.
- Department of Biology, College of Science, Qassim University, Buraydah 51452, Saudi Arabia.
ORCID-Profile: Syeda Ayesha Farhana, Abdul Rehman, Saqib Khan, Iffat Naz
Förderung
- Qassim University
Zitieren
APA
Zia-Ul-Haq, M., Kaleem, W. A., Farhana, S. A., Shah, S. U. A., Rehman, A., Khan, S., & Naz, I. (2026). In Silico and In Vitro Evaluation of Bioactive Constituents Isolated from Ziziphus oxyphylla for the Treatment of Diabetes. Biomolecules, 16(5), 700. https://doi.org/10.3390/biom16050700
Vancouver
Zia-Ul-Haq M, Kaleem WA, Farhana SA, Shah SUA, Rehman A, Khan S, et al. In Silico and In Vitro Evaluation of Bioactive Constituents Isolated from Ziziphus oxyphylla for the Treatment of Diabetes. Biomolecules. 2026;16(5):700. doi:10.3390/biom16050700
BibTeX
@article{ZiaUlHaq2026,
author = {Zia-Ul-Haq, Muhammad and Kaleem, Waqar Ahmad and Farhana, Syeda Ayesha and Shah, Syed Uzair Ali and Rehman, Abdul and Khan, Saqib and Naz, Iffat},
title = {In Silico and In Vitro Evaluation of Bioactive Constituents Isolated from Ziziphus oxyphylla for the Treatment of Diabetes},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {5},
pages = {700},
doi = {10.3390/biom16050700}
}
EUVIMED